As biologics gain greater prominence, protein engineers adjust their foci to new indications, improved targeting, new formats, and products that are truly differentiated relative to competitors. The Protein Engineering & Development pipeline offers a weeklong exploration of state-of-the-art approaches for developing safe and effective protein and antibody-based therapeutics, including improving qualities, enhancing efficacy, and fine-tuning manufacturing.
Recombinant Protein Therapeutics
Enhancing Antibody Binding and Specificity
Emerging Technologies for Antibody Discovery